Cenovus Energy (NYSE:CVE) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $0.82 by 45.12 percent. This is a 1222.22 percent increase over earnings of $0.09 per share from the same period last year.
Blueprint Medicines’s Return On Capital Employed Overview
According to Benzinga Pro data, during Q1, Blueprint Medicines (NASDAQ:BPMC) posted sales of $63.29 million. Earnings were up…